BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 7909572)

  • 1. Clinical relevance of P-glycoprotein expression in haematological malignancies.
    Nooter K; Sonneveld P
    Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance (MDR) genes in haematological malignancies.
    Nooter K; Sonneveld P
    Cytotechnology; 1993; 12(1-3):213-30. PubMed ID: 7765326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance: clinical relevance in haematological malignancies.
    Kaye SB; Kerr DJ
    Blood Rev; 1991 Mar; 5(1):38-41. PubMed ID: 1674435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of multidrug resistance in cancer chemotherapy.
    Nooter K; Stoter G
    Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
    Pasman PC; Schouten HC
    Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of multidrug resistance 1 and correlation with clinical drug resistance in acute leukemia].
    Asou N; Nishikawa K; Suzushima H; Takatsuki K
    Nihon Rinsho; 1992 Jun; 50(6):1400-6. PubMed ID: 1355571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
    Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
    Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
    Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
    Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.
    van den Heuvel-Eibrink MM; Sonneveld P; Pieters R
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):94-110. PubMed ID: 10739113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of multidrug resistance (MDR) in hematological malignancies.
    Covelli A
    Ann Oncol; 1999; 10 Suppl 6():53-9. PubMed ID: 10676553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance-associated protein (MRP) in haematological malignancies.
    Nooter K; Burger H; Stoter G
    Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
    Nielsen D; Skovsgaard T
    Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug.
    Center MS
    Cytotechnology; 1993; 12(1-3):109-25. PubMed ID: 7765322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidrug resistance induced by surexpression of the mdrl gene].
    Guerci AP
    Rev Med Interne; 1993; 14(8):772-9. PubMed ID: 7910697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.
    Roepe PD; Wei LY; Cruz J; Carlson D
    Biochemistry; 1993 Oct; 32(41):11042-56. PubMed ID: 8105888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance in leukaemia.
    Baines P; Cumber P; Padua RA
    Baillieres Clin Haematol; 1992 Oct; 5(4):943-60. PubMed ID: 1364045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives.
    Hegewisch-Becker S; Hossfeld DK
    Ann Hematol; 1996 Mar; 72(3):105-17. PubMed ID: 8766251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of MDR-1 gene expression on outcome in acute myeloblastic leukaemia.
    Holmes JA; West RR
    Br J Cancer; 1994 Feb; 69(2):382-4. PubMed ID: 7905280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport and metabolism of polyamines in wild and multidrug resistant human leukemia (K 562) cells.
    Khan NA; Fardel O; Havouis R; Fauchet R; Moulinoux JP
    Leuk Res; 1994 Apr; 18(4):283-91. PubMed ID: 7909574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].
    Sonneveld P; te Boekhorst PA
    Ned Tijdschr Geneeskd; 1994 Mar; 138(10):508-12. PubMed ID: 7908127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.